{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:00:04Z","timestamp":1765890004779,"version":"3.48.0"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Guard Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a common complication after cardiac surgery (CS) and is associated with adverse short-term and long-term outcomes. Alpha-1-microglobulin (A1M) is a circulating glycoprotein with antioxidant, heme binding and mitochondrial-protective mechanisms. RMC-035 is a modified, more soluble, variant of A1M and has been proposed as a novel targeted therapeutic protein to prevent CS-associated AKI (CS-AKI). RMC-035 was considered safe and generally well tolerated when evaluated in four clinical phase 1 studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a phase 2, randomised, double-blind, adaptive design, parallel group clinical study that evaluates RMC-035 compared with placebo in approximately 268 cardiac surgical patients at high risk for CS-AKI. RMC-035 is administered as an intravenous infusion. In total, five doses will be given. Dosing is based on presurgery estimated glomerular filtration rate (eGFR), and will be either 1.3 or 0.65\u2009mg\/kg.<\/jats:p>\n                    <jats:p>The primary study objective is to evaluate whether RMC-035 reduces the incidence of postoperative AKI, and key secondary objectives are to evaluate whether RMC-035 improves postoperative renal function compared with placebo. A blinded interim analysis with potential sample size reassessment is planned once 134 randomised subjects have completed dosing. An independent data monitoring committee will evaluate safety and efficacy data at prespecified intervals throughout the trial. The study is a global multicentre study at approximately 30 sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial was approved by the joint ethics committee of the physician chamber Westfalen-Lippe and the University of M\u00fcnster (code \u20182021-778\u2009f-A\u2019) and subsequently approved by the responsible ethics committees\/relevant institutional review boards for the participating sites. The study is conducted in accordance with Good Clinical Practice, the Declaration of Helsinki and other applicable regulations. Results of this study will be published in a peer-reviewed scientific journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05126303\">NCT05126303<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-068363","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T10:53:21Z","timestamp":1680778401000},"page":"e068363","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05126303","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-4308","authenticated-orcid":false,"given":"C David","family":"Mazer","sequence":"first","affiliation":[{"name":"Department of Anesthesia, St. Michael's Hospital, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology and Pain Medicine, Physiology and Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Siadati-Fini","sequence":"additional","affiliation":[{"name":"Anaesthesia Department, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Boehm","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Technische Universit\u00e4t M\u00fcnchen, Munchen, Germany"},{"name":"Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Wirth","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Technische Universit\u00e4t M\u00fcnchen, Munchen, Germany"},{"name":"Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Myjavec","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University of Hradec Kralove, Hradec Kralove, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig D","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay L","family":"Koyner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Nephrology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Boening","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T","family":"Engelman","sequence":"additional","affiliation":[{"name":"Heart and Vascular Program, Baystate Medical Center, Springfield, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias E","family":"Larsson","sequence":"additional","affiliation":[{"name":"Guard Therapeutics, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny","family":"Renfurm","sequence":"additional","affiliation":[{"name":"Global Drug Development Unit Cardio-Renal-Metabolism, Novartis Pharma AG, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"de Varennes","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, McGill University Faculty of Medicine, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Noiseux","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Universite de Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Thielmann","sequence":"additional","affiliation":[{"name":"Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Lamy","sequence":"additional","affiliation":[{"name":"Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany"},{"name":"Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Laflamme","sequence":"additional","affiliation":[{"name":"Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, University of Quebec, Quebec, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5287-1137","authenticated-orcid":false,"given":"Thilo","family":"von Groote","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care Medicine, University Hospital M\u00fcnster, Munster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[{"name":"International Renal Research Institute of Vicenza, San Bortolo Hospital of Vicenza, Vicenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-1714","authenticated-orcid":false,"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care Medicine, University Hospital M\u00fcnster, Munster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"2025121604562292000_13.4.e068363.1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010121302"},{"key":"2025121604562292000_13.4.e068363.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.05.131"},{"key":"2025121604562292000_13.4.e068363.3","first-page":"397","article-title":"The incidence of acute kidney injury and associated hospital mortality","volume":"116","author":"Khadzhynov","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"2025121604562292000_13.4.e068363.4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/IJNRD.S167477","article-title":"Acute kidney injury after cardiac surgery: prevalence, impact and management challenges","volume":"12","author":"Vives","year":"2019","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2025121604562292000_13.4.e068363.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2015.07.013"},{"key":"2025121604562292000_13.4.e068363.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2015.06.017"},{"key":"2025121604562292000_13.4.e068363.7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.athoracsur.2017.10.053","article-title":"Financial impact of acute kidney injury after cardiac operations in the United States","volume":"105","author":"Alshaikh","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2025121604562292000_13.4.e068363.8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12882-015-0066-9","article-title":"Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the rifle classification","volume":"16","author":"Lagny","year":"2015","journal-title":"BMC Nephrol"},{"key":"2025121604562292000_13.4.e068363.9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.31083\/j.rcm.2020.04.206","article-title":"Determinants of acute kidney injury after cardiac surgery: a systematic review","volume":"21","author":"Tinica","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"2025121604562292000_13.4.e068363.10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003549","article-title":"ABT-719 for the prevention of acute kidney injury in patients undergoing high-risk cardiac surgery: a randomized phase 2B clinical trial","volume":"5","author":"McCullough","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2025121604562292000_13.4.e068363.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4670-3"},{"key":"2025121604562292000_13.4.e068363.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252209","article-title":"Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery","volume":"16","author":"Serraino","year":"2021","journal-title":"PLoS One"},{"key":"2025121604562292000_13.4.e068363.13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5830\/CVJA-2020-063","article-title":"Factors associated with acute kidney injury and mortality during cardiac surgery","volume":"32","author":"Leballo","year":"2021","journal-title":"Cardiovasc J Afr"},{"key":"2025121604562292000_13.4.e068363.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1352-z","article-title":"Acute kidney injury following cardiac surgery: current understanding and future directions","volume":"20","author":"O\u2019Neal","year":"2016","journal-title":"Crit Care"},{"key":"2025121604562292000_13.4.e068363.15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2014.06.025","article-title":"A1M, an extravascular tissue cleaning and housekeeping protein","volume":"74","author":"\u00c5kerstr\u00f6m","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"2025121604562292000_13.4.e068363.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027505","article-title":"Up-regulation of A1M\/\u03b11-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage","volume":"6","author":"Olsson","year":"2011","journal-title":"PLoS One"},{"key":"2025121604562292000_13.4.e068363.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.10.052"},{"key":"2025121604562292000_13.4.e068363.18","doi-asserted-by":"publisher","DOI":"10.1080\/10715760802337265"},{"key":"2025121604562292000_13.4.e068363.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2011.01.017"},{"key":"2025121604562292000_13.4.e068363.20","doi-asserted-by":"crossref","unstructured":"KDIGO . KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl (2011) 2012;2. doi:10.1038\/kisup.2012.2","DOI":"10.1038\/kisup.2012.2"},{"key":"2025121604562292000_13.4.e068363.21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCULATIONAHA.120.053029","article-title":"Teprasiran, a small interfering RNA, for the prevention of acute kidney injury in high-risk patients undergoing cardiac surgery: a randomized clinical study","volume":"144","author":"Thielmann","year":"2021","journal-title":"Circulation"},{"key":"2025121604562292000_13.4.e068363.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"2025121604562292000_13.4.e068363.23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121604562292000_13.4.e068363.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.05.019"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-068363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:56:29Z","timestamp":1765889789000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-068363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,6]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjopen-2022-068363"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-068363","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}